Pearce IP and its team members are ranked in virtually every notable legal and attorney listing for Australia. We have received numerous awards celebrating both the exceptional talent of our people and the high standard of excellence we bring to legal and IP services across Australia and New Zealand. Our recognition extends beyond professional excellence to our workplace culture, with awards including the 5-Star Employer of Choice 2025 & “Standout Winner” for Inclusion and Culture 2025 from Australasian Lawyer and New Zealand Lawyer.
2 Pearce IP Experts Recognised as Asia IP 2026 Australia IP Experts for Patents and Pharma & Biotech. Naomi Pearce and Jacinta Flattery-O’Brien have both been recognised in Asia IP’s IP Experts Australia 2026, published in April 2026.
CEO and Founder Naomi Pearce has been recommended in the Lexology Index – Healthcare & Life Sciences 2026, with recognition in the highly competitive Patent Litigation category.
Helen Macpherson, Pearce IP’s Executive Lawyer and Head of Litigation (Australia), has been recognised in 2027 The Best Lawyers in Australia™ for Intellectual Property Law and Life Sciences. Helen has been listed by Best Lawyers every year since 2017.
Pearce IP Ranked in Three Categories in the 2026 Asia IP Australia Law Firm Rankings. Pearce IP was ranked in Australia for Patent Prosecution (Tier 1), Patent Contentious, and Trade Mark Prosecution.
Pearce IP’s strong performance in Asia IP’s 2025 rankings was followed by a major achievement for its New Zealand practice, with the office named New Zealand Patent Prosecution Firm of the Year at the 2025 Asia IP Awards. The recognition is particularly significant for a practice that entered the New Zealand market less than two years earlier.
WTR1000 2026 | Pearce IP “Shaking the Trans-Tasman Market”. Pearce IP, and 5 of its Executives, in Australia and New Zealand have been ranked in WTR 1000 2026 for trade marks: Litigation and Prosecution & Strategy. WTR 1000 was glowing in its commentary of Pearce IP…
In addition to recent rankings in the Chambers 2026 Asia-Pacific Guide, Pearce IP, with CEO Naomi Pearce and Executive & Head of Litigation Helen Macpherson, have been ranked overnight in the 2026 Chambers Global Guide. Whilst Chambers Asia-Pacific honours the best law firms and lawyers within the Asia-Pacific regional legal market, Chambers Global focuses on law firms and lawyers…
Pearce IP and Chantal Savage, have been ranked in Australia for Intellectual Property in the Legal 500 Asia Pacific 2026 Rankings. Legal 500 rankings take in a broad scope of client and law firm information, combining qualitative and quantitative data to create a strategic compass for clients who are searching for the best legal advisers for their type of work.
Pearce IP’s CEO and Founder, Naomi Pearce, has been recognised in the IAM Strategy 300 Global Leaders 2026 – the annual showcase of the world’s leading IP strategists. This latest honour follows her previous inclusions in 2020, 2021 and 2022.
Pearce IP and Leaders Recognised in Chambers Asia-Pacific 2026 Rankings for Third Consecutive Year
Founder and CEO of Pearce IP, Naomi Pearce, has been recognised as the 2026 Client Choice Award winner for Intellectual Property – Patents (Australia) by Lexology. Established in 2005, the Client Choice Awards celebrate those law firms and partners around the world who stand apart for the excellence of their client care and quality of service.
Pearce IP’s CEO & Founder Naomi Pearce recognised in IAM Global Leaders 2026 which showcases patent leaders in IAM Patent 1000 gold tier who merit special attention.
Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.
Global - Intellectual Property (2026, 2025)
Asia Pacific - Intellectual Property (2026, 2025, 2024)
Winner - Asia Pacific and Greater China Region Awards 2025 - DEI: Outstanding Firm (2025)
Market Leading Intellectual Property Firm (2026, 2025, 2024, 2023)
New Zealand Patent Prosecution Firm of the Year (2025)
Patent Prosecution (2026, 2025, 2024, 2023)
Patent Contentious (2026, 2025)
Trademark Prosecution (2026)
Patent Prosecution (2026)
Patent - Patent Prosecution (Australia) (2025, 2024)
Silver - Litigation (Australia) (2026, 2025)
Silver - Prosecution (Australia) (2026, 2025)
Bronze - Prosecution (New Zealand) (2026, 2025)
Bronze - Litigation (Australia) (2023, 2022, 2021)
Bronze - Prosecution (Australia) (2024, 2023, 2022, 2021)
Finalist – Women in Law Awards – Boutique Diversity Firm of the Year (2022)
Finalist – Intellectual Property Team of the Year (2022)
Winner – Intellectual Property Team of the Year (2021)
Patent Prosecution - AU (2026, 2025, 2024, 2023, 2022)
Trade Mark - Patent & Trade Mark Attorney Firms - AU (2026, 2025)
Patent Disputes - AU (2026, 2025)
Trade Mark Prosecution - NZ (2026)
The Only Leading Female Owned Life Sciences focussed IP Firm (2023)
Pearce IP ranked firm (2021)
Prosecution & Strategy, Australia and New Zealand (2026)
Litigation & Prosecution Australia - Silver (2025)
Litigation & Prosecution New Zealand (2025)
Litigation & Prosecution Australia (2024)
Best Law Firm - Australia (2027, 2026)
Shortlisted – Australian Firm of the Year (2022)
Australasia – Healthcare & Life Sciences (Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020)
Australasia - Dispute Resolution (Q1 2026, Q4 2025)
Cross-border – Healthcare & Life Sciences (Q1 2026, Q4 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023)
Europe – Healthcare & Life Sciences (Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024)
Top Specialist Firm (2026, 2025)
5-Star Employer of Choice (2025)
"Standout Winner” for Inclusion and Culture (<100 employees) (2025)
Top Boutique Firm (2024)
5-Star Intellectual Property Law Firm (2021)
Leading Intellectual Property (2021, 2020)
Leading Contentious Intellectual Property Law Firm (2026, 2025)
Finalist – Intellectual Property Partner of the Year (2025, 2024, 2022)
Winner – Intellectual Property Partner of the Year (2023)
Intellectual Property: Patents – Global (2026, 2025)
Intellectual Property: Patents – Asia Pacific (2026, 2025, 2024)
Life Sciences - Asia Pacific (2026, 2025, 2024)
Recommended - Leading Contentious Intellectual Property Lawyer in NSW (2026, 2025)
Elite Women (2025)
Most Influential Lawyers – Changemaker (2024, 2023, 2022)
5-Star Intellectual Property Lawyer – General IP (2021)
Influential Women in IP (2026)
WIPR Leader (2025, 2024, 2023, 2022)
WIPR Diversity Champion (2025, 2022)
Top 100 Influential Women in IP (2021)
WIPR Leaders – Patents & Trade Marks (2022, 2021, 2020)
Patents (2026, 2025, 2024, 2023)
Pharma & Biotech (2026, 2025)
Global Leader (2026)
Gold – Litigation (2026, 2025)
Gold – Prosecution (2026, 2025)
Silver – Litigation (2024, 2023, 2022, 2021)
Recommended for litigation (2020)
Legal (2026, 2025, 2024)
IP Management Consultancy (2026, 2025, 2024)
Pharmaceuticals/Life Sciences (2024)
Global Leader (2026, 2022, 2021, 2020)
World Leading IP Strategist (2022, 2021, 2020)
Patent Star (2026, 2025, 2024, 2023, 2022, 2021)
Practitioner of the Year Finalist (2023)
Silver - Prosecution & Strategy (Australia) (2026, 2025)
Winner – Patent Lawyer of the Year (2022)
Shortlisted – Life Sciences Lawyer of the Year (2022)
Winner – Client Choice Award for IP Patents (2026)
Winner – Client Choice Award for Life Sciences (2022)
Intellectual Property - Patents (2026)
Healthcare & Life Sciences - Patent Litigation (2026)
Australia & New Zealand - IP-Patents (2026, 2025)
Australia & New Zealand - Life Sciences (2026, 2025)
Australia & New Zealand - IP-Trade Mark Agents & Attorneys (2026)
Winner - Executive of the Year (2024)
Finalist - Executive of the Year (2024)
Winner – Partner of the Year (SME Law) (2021)
Australasia - Dispute Resolution (Q3 2025, Q1 2025)
Australasia – Healthcare & Life Sciences (Q2 2024, Q1 2024 Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020, Q3 2020)
Asia-Pacific – Healthcare & Life Sciences (Q1 2024, Q4 2023, Q3 2023)
US – Healthcare & Life Sciences (Q4 2023, Q3 2023, Q2 2023)
Cross-border – Healthcare & Life Sciences (Q3 2024, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023, Q4 2022, Q3 2021)
Canada – Healthcare & Life Sciences (Q4 2023, Q2 2023)
Europe – Healthcare & Life Sciences (Q4 2023)
Intellectual Property: Patents - Global (2026, 2025)
Intellectual Property: Patents - Asia Pacific (2026, 2025, 2024)
Patents Star (2026, 2025, 2024, 2023)
Silver – Litigation (2026, 2025, 2024, 2023, 2022)
Silver – Transactions (2026, 2025, 2024)
Ranked as a market leading Intellectual Property (2023)
Enforcement & Litigation (Australia) (2026, 2025)
Intellectual Property (2027, 2026, 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016)
Life Sciences (2027, 2026)
Patent Lawyer of the Year (2021)
Intellectual Property - Copyright (2026)
Australia & New Zealand - IP-Patents (2026)
Australia & New Zealand - IP-Copyright (2026, 2025)
Australasia – Dispute Resolution (Q1 2026, Q4 2025)
Intellectual Property - Asia Pacific (2026, 2025, 2024)
Notable Practitioner (2026, 2025, 2024)
Litigation (2026, 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016)
Enforcement & Litigation (New Zealand) (2026, 2025)
Recommended individual – Enforcement & Litigation (2024, 2023, 2022)
Patents (2026, 2023, 2022)
Pharma & Biotech (2026)
Trade Marks (2026, 2023, 2022)
Copyright (2026, 2023, 2022)
IP Litigation (2026, 2023, 2022)
Media & Entertainment (2026)
Enforcement (2023, 2022)
Intellectual Property & Litigation (2024, 2023, 2022, 2019)
Leading Intellectual Property Lawyer (2026)
WIPR Leader (2024, 2023, 2022)
Patent Leader (2023, 2022, 2021)
Notable Practitioner (2026, 2025)
Patent Star (2024, 2023, 2022, 2021, 2020)
Silver ranking – Prosecution (2026, 2025, 2024, 2023)
Highly Recommended – Prosecution (2023, 2022)
WIPR Leader (2024)
Next Generation Leader (2026)
Recommended Individual (2025)
Leading Associate in Intellectual Property (2026, 2025)
Rising Star in Intellectual Property (2024)
Rising Star in Intellectual Property (2023)
Rising Star in Intellectual Property (2022)
Rising Star in Intellectual Property (2021)
By 2027, be the premier life sciences IP practice in
Australia and New Zealand.
